We identified new users of GLP-1 RAs (exenatide, dulaglutide, liraglutide, or semaglutide) and DPP-4is (sitagliptin, saxagliptin, linagliptin, or alogliptin) based on first dispensed prescription for 1 of these drugs in the VHA with a look-back period of 6 months
10.1016/j.advms.2016.11.001 Adv
Made in France High Standards Designed and manufactured in France, our products are traced, analyzed and undergo a strict manufacturing process and controls in laboratory certified ISO9001 - ISO22000 with HACCP protocol
Antioxidant Protection Once in the bloodstream, glutathione acts as a powerful antioxidant, neutralizing harmful free radicals and reactive oxygen species (ROS) that can damage cells and DNA
Additionally, other factors such as increased fluid intake or co-prescribed medications (particularly SGLT2 inhibitors or diuretics) are more likely explanations for increased urination than the GLP-1 medication itself